Risk of keratinocyte carcinomas with vitamin D and calcium supplementation: a secondary analysis of a randomized clinical trial
- 10 December 2020
- journal article
- research article
- Published by Elsevier in The American Journal of Clinical Nutrition
- Vol. 112 (6) , 1532-1539
Abstract
It is unknown whether dietary supplementation with vitamin D or calcium prevents keratinocyte carcinomas, also known as nonmelanoma skin cancers. This study aimed to determine whether daily vitamin D or calcium supplementation alters the risk of basal cell carcinoma (BCC) or invasive cutaneous squamous cell carcinoma (SCC). The Vitamin D/Calcium Polyp Prevention Study is a completed multicenter, double-blind, placebo-controlled, partial 2 × 2 factorial, randomized clinical trial of vitamin D, calcium, or both for the prevention of colorectal adenomas. During 2004-2008, a total of 2259 men and women, 45-75 y of age, recently diagnosed with a colorectal adenoma, were randomly assigned to 1000 IU/d of vitamin D3 or placebo and 1200 mg/d of calcium carbonate or placebo for 3 or 5 y, and followed after treatment ended. Reports of incident BCC or SCC were confirmed from pathology records. During a median follow-up of 8 y, 200 (9%) participants were diagnosed with BCC and 68 (3%) participants were diagnosed with SCC. BCC incidence was unrelated to treatment with vitamin D compared with no vitamin D (HR: 0.96; 95% CI: 0.73, 1.26), calcium compared with no calcium (HR: 1.01; 95% CI: 0.74, 1.39), and both agents compared with neither (HR: 0.99; 95% CI: 0.65, 1.51). SCC incidence was unrelated to treatment with vitamin D compared with no vitamin D (HR: 0.79; 95% CI: 0.49, 1.27), but there was suggestive evidence of beneficial treatment effects for calcium compared with no calcium (HR: 0.60; 95% CI: 0.36, 1.01) and both agents compared with neither (HR: 0.42; 95% CI: 0.19, 0.91). Calcium alone or in combination with vitamin D may reduce the risk of SCC, but not BCC. This trial was registered at clinicaltrials.gov as NCT00153816.Keywords
Funding Information
- NIH
- National Cancer Institute (R01CA098286)
- National Institute of General Medical Sciences (P20GM104416)
- Pfizer Consumer Healthcare
This publication has 58 references indexed in Scilit:
- Health risks and benefits from calcium and vitamin D supplementation: Women's Health Initiative clinical trial and cohort studyOsteoporosis International, 2012
- Vitamin D in cutaneous carcinogenesisJournal of the American Academy of Dermatology, 2012
- Dietary Supplements and Cancer Prevention: Balancing Potential Benefits Against Proven HarmsJNCI: Journal of the National Cancer Institute, 2012
- Supplement use and risk of cutaneous squamous cell carcinomaJournal of the American Academy of Dermatology, 2011
- The Effect of Calcium plus Vitamin D on Risk for Invasive Cancer: Results of the Women's Health Initiative (WHI) Calcium Plus Vitamin D Randomized Clinical TrialNutrition and Cancer, 2011
- Increased Risk for Non-Melanoma Skin Cancer in Patients With Inflammatory Bowel DiseaseClinical Gastroenterology and Hepatology, 2010
- Vascular events in healthy older women receiving calcium supplementation: randomised controlled trialBMJ, 2008
- Vitamin D DeficiencyNew England Journal of Medicine, 2007
- Calcium plus Vitamin D Supplementation and the Risk of FracturesNew England Journal of Medicine, 2006
- Effect of four monthly oral vitamin D 3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trialBMJ, 2003